nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.197	0.504	CbGbCtD
Risedronate—PTGS2—Etoposide—peripheral nervous system neoplasm	0.194	0.496	CbGbCtD
Risedronate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00047	0.000771	CcSEcCtD
Risedronate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000469	0.000769	CcSEcCtD
Risedronate—Cough—Etoposide—peripheral nervous system neoplasm	0.000468	0.000768	CcSEcCtD
Risedronate—Headache—Topotecan—peripheral nervous system neoplasm	0.000467	0.000767	CcSEcCtD
Risedronate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000467	0.000766	CcSEcCtD
Risedronate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000467	0.000766	CcSEcCtD
Risedronate—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000466	0.000766	CcSEcCtD
Risedronate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000466	0.000765	CcSEcCtD
Risedronate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000466	0.000765	CcSEcCtD
Risedronate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000466	0.000765	CcSEcCtD
Risedronate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000464	0.000762	CcSEcCtD
Risedronate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000464	0.000762	CcSEcCtD
Risedronate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000464	0.000761	CcSEcCtD
Risedronate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000464	0.000761	CcSEcCtD
Risedronate—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000463	0.00076	CcSEcCtD
Risedronate—Pain—Vincristine—peripheral nervous system neoplasm	0.000462	0.000758	CcSEcCtD
Risedronate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000462	0.000758	CcSEcCtD
Risedronate—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000758	CcSEcCtD
Risedronate—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000758	CcSEcCtD
Risedronate—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000756	CcSEcCtD
Risedronate—Rash—Melphalan—peripheral nervous system neoplasm	0.00046	0.000756	CcSEcCtD
Risedronate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00046	0.000755	CcSEcCtD
Risedronate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.000753	CcSEcCtD
Risedronate—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000457	0.000749	CcSEcCtD
Risedronate—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000748	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000453	0.000744	CcSEcCtD
Risedronate—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000451	0.00074	CcSEcCtD
Risedronate—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000733	CcSEcCtD
Risedronate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000446	0.000731	CcSEcCtD
Risedronate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.000731	CcSEcCtD
Risedronate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.000727	CcSEcCtD
Risedronate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.000727	CcSEcCtD
Risedronate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000443	0.000727	CcSEcCtD
Risedronate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000442	0.000725	CcSEcCtD
Risedronate—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000725	CcSEcCtD
Risedronate—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00044	0.000723	CcSEcCtD
Risedronate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000439	0.000721	CcSEcCtD
Risedronate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000439	0.000721	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000435	0.000714	CcSEcCtD
Risedronate—Infection—Etoposide—peripheral nervous system neoplasm	0.000435	0.000714	CcSEcCtD
Risedronate—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000713	CcSEcCtD
Risedronate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000434	0.000712	CcSEcCtD
Risedronate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000434	0.000712	CcSEcCtD
Risedronate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000431	0.000708	CcSEcCtD
Risedronate—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000431	0.000708	CcSEcCtD
Risedronate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000429	0.000704	CcSEcCtD
Risedronate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000427	0.000701	CcSEcCtD
Risedronate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000427	0.000701	CcSEcCtD
Risedronate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.0007	CcSEcCtD
Risedronate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000426	0.000699	CcSEcCtD
Risedronate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000425	0.000698	CcSEcCtD
Risedronate—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000692	CcSEcCtD
Risedronate—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00069	CcSEcCtD
Risedronate—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000685	CcSEcCtD
Risedronate—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000681	CcSEcCtD
Risedronate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000414	0.000679	CcSEcCtD
Risedronate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000413	0.000678	CcSEcCtD
Risedronate—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000678	CcSEcCtD
Risedronate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000412	0.000677	CcSEcCtD
Risedronate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000671	CcSEcCtD
Risedronate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000409	0.000671	CcSEcCtD
Risedronate—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000669	CcSEcCtD
Risedronate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000402	0.00066	CcSEcCtD
Risedronate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.00066	CcSEcCtD
Risedronate—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000658	CcSEcCtD
Risedronate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000655	CcSEcCtD
Risedronate—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000655	CcSEcCtD
Risedronate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000398	0.000653	CcSEcCtD
Risedronate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.000651	CcSEcCtD
Risedronate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000393	0.000645	CcSEcCtD
Risedronate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00039	0.00064	CcSEcCtD
Risedronate—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000638	CcSEcCtD
Risedronate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000388	0.000636	CcSEcCtD
Risedronate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000635	CcSEcCtD
Risedronate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000631	CcSEcCtD
Risedronate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000631	CcSEcCtD
Risedronate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000385	0.000631	CcSEcCtD
Risedronate—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.00063	CcSEcCtD
Risedronate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.00063	CcSEcCtD
Risedronate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000381	0.000626	CcSEcCtD
Risedronate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000378	0.00062	CcSEcCtD
Risedronate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000378	0.00062	CcSEcCtD
Risedronate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000377	0.000619	CcSEcCtD
Risedronate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000374	0.000614	CcSEcCtD
Risedronate—Pain—Etoposide—peripheral nervous system neoplasm	0.000374	0.000614	CcSEcCtD
Risedronate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000614	CcSEcCtD
Risedronate—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000614	CcSEcCtD
Risedronate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000609	CcSEcCtD
Risedronate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.000609	CcSEcCtD
Risedronate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00037	0.000607	CcSEcCtD
Risedronate—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000597	CcSEcCtD
Risedronate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000592	CcSEcCtD
Risedronate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000359	0.00059	CcSEcCtD
Risedronate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000588	CcSEcCtD
Risedronate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000358	0.000587	CcSEcCtD
Risedronate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000357	0.000586	CcSEcCtD
Risedronate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000357	0.000585	CcSEcCtD
Risedronate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000584	CcSEcCtD
Risedronate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000584	CcSEcCtD
Risedronate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.00058	CcSEcCtD
Risedronate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.00058	CcSEcCtD
Risedronate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000352	0.000578	CcSEcCtD
Risedronate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.000576	CcSEcCtD
Risedronate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000348	0.000571	CcSEcCtD
Risedronate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000347	0.00057	CcSEcCtD
Risedronate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000568	CcSEcCtD
Risedronate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000346	0.000568	CcSEcCtD
Risedronate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000346	0.000568	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000568	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000568	CcSEcCtD
Risedronate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000567	CcSEcCtD
Risedronate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000344	0.000564	CcSEcCtD
Risedronate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000343	0.000563	CcSEcCtD
Risedronate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000563	CcSEcCtD
Risedronate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000341	0.00056	CcSEcCtD
Risedronate—Rash—Vincristine—peripheral nervous system neoplasm	0.000341	0.000559	CcSEcCtD
Risedronate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00034	0.000559	CcSEcCtD
Risedronate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00034	0.000558	CcSEcCtD
Risedronate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000557	CcSEcCtD
Risedronate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000339	0.000556	CcSEcCtD
Risedronate—Headache—Vincristine—peripheral nervous system neoplasm	0.000338	0.000556	CcSEcCtD
Risedronate—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.000552	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000548	CcSEcCtD
Risedronate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000333	0.000547	CcSEcCtD
Risedronate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000327	0.000536	CcSEcCtD
Risedronate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00053	CcSEcCtD
Risedronate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000322	0.000529	CcSEcCtD
Risedronate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000528	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000527	CcSEcCtD
Risedronate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000321	0.000527	CcSEcCtD
Risedronate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000526	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000526	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000524	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00052	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000518	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000517	CcSEcCtD
Risedronate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000314	0.000515	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000314	0.000515	CcSEcCtD
Risedronate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000514	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000514	CcSEcCtD
Risedronate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000512	CcSEcCtD
Risedronate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000511	CcSEcCtD
Risedronate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00031	0.000508	CcSEcCtD
Risedronate—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000506	CcSEcCtD
Risedronate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000304	0.000499	CcSEcCtD
Risedronate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000497	CcSEcCtD
Risedronate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000494	CcSEcCtD
Risedronate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000494	CcSEcCtD
Risedronate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000493	CcSEcCtD
Risedronate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000299	0.000491	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.00049	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000489	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000487	CcSEcCtD
Risedronate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000486	CcSEcCtD
Risedronate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000477	CcSEcCtD
Risedronate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000476	CcSEcCtD
Risedronate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000289	0.000475	CcSEcCtD
Risedronate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000474	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000474	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000473	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000468	CcSEcCtD
Risedronate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000284	0.000466	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000459	CcSEcCtD
Risedronate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000278	0.000457	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000457	CcSEcCtD
Risedronate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000456	CcSEcCtD
Risedronate—Rash—Etoposide—peripheral nervous system neoplasm	0.000276	0.000453	CcSEcCtD
Risedronate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000276	0.000452	CcSEcCtD
Risedronate—Headache—Etoposide—peripheral nervous system neoplasm	0.000274	0.00045	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.00045	CcSEcCtD
Risedronate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000443	CcSEcCtD
Risedronate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000442	CcSEcCtD
Risedronate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000442	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000439	CcSEcCtD
Risedronate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000434	CcSEcCtD
Risedronate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000431	CcSEcCtD
Risedronate—Nausea—Etoposide—peripheral nervous system neoplasm	0.00026	0.000427	CcSEcCtD
Risedronate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000426	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000422	CcSEcCtD
Risedronate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.00042	CcSEcCtD
Risedronate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000256	0.00042	CcSEcCtD
Risedronate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.00042	CcSEcCtD
Risedronate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000419	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000417	CcSEcCtD
Risedronate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000411	CcSEcCtD
Risedronate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.00041	CcSEcCtD
Risedronate—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000409	CcSEcCtD
Risedronate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000401	CcSEcCtD
Risedronate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000244	0.0004	CcSEcCtD
Risedronate—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000398	CcSEcCtD
Risedronate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000396	CcSEcCtD
Risedronate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000395	CcSEcCtD
Risedronate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000394	CcSEcCtD
Risedronate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000391	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000389	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000389	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000389	CcSEcCtD
Risedronate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000387	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000386	CcSEcCtD
Risedronate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00038	CcSEcCtD
Risedronate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00037	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000367	CcSEcCtD
Risedronate—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000367	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000365	CcSEcCtD
Risedronate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000364	CcSEcCtD
Risedronate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000362	CcSEcCtD
Risedronate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000362	CcSEcCtD
Risedronate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000359	CcSEcCtD
Risedronate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000354	CcSEcCtD
Risedronate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000348	CcSEcCtD
Risedronate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000347	CcSEcCtD
Risedronate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000344	CcSEcCtD
Risedronate—Pain—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000344	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000339	CcSEcCtD
Risedronate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000337	CcSEcCtD
Risedronate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000335	CcSEcCtD
Risedronate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000332	CcSEcCtD
Risedronate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000329	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000328	CcSEcCtD
Risedronate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000322	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000321	CcSEcCtD
Risedronate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00032	CcSEcCtD
Risedronate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000319	CcSEcCtD
Risedronate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000319	CcSEcCtD
Risedronate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000318	CcSEcCtD
Risedronate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000318	CcSEcCtD
Risedronate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000305	CcSEcCtD
Risedronate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000297	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000296	CcSEcCtD
Risedronate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000295	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000295	CcSEcCtD
Risedronate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000289	CcSEcCtD
Risedronate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000285	CcSEcCtD
Risedronate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000276	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000274	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000267	CcSEcCtD
Risedronate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000266	CcSEcCtD
Risedronate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000264	CcSEcCtD
Risedronate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000256	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000255	CcSEcCtD
Risedronate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000254	CcSEcCtD
Risedronate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000254	CcSEcCtD
Risedronate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000252	CcSEcCtD
Risedronate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000246	CcSEcCtD
Risedronate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000239	CcSEcCtD
Risedronate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000237	CcSEcCtD
Risedronate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000235	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000235	CcSEcCtD
Risedronate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000233	CcSEcCtD
Risedronate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000221	CcSEcCtD
